BioCryst Pharmaceuticals (BCRX) had the best year in Q3 2013 by a US stock in 2013, returning 366.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
BioCryst Pharmaceuticals (BCRX) | 2013 | 366.67% |
GT Biopharma (GTBP) | 2013 | 326.92% |
Armata Pharmaceuticals (ARMP) | 2013 | 240% |
Scienture (SCNX) | 2013 | 228.57% |
Iovance Biotherapeutics (IOVA) | 2013 | 227.5% |
Rockwell Medical (RMTI) | 2013 | 211.5% |
Duos Technologies (DUOT) | 2013 | 200% |
Dolphin Entertainment (DLPN) | 2013 | 200% |
Daqo New Energy Corp ADR (DQ) | 2013 | 187.61% |
Quantum X Labs (QXL) | 2013 | 183.33% |
Viewbix Inc Common Stock (VBIX) | 2013 | 183.33% |
Arrowhead Pharmaceuticals (ARWR) | 2013 | 180.3% |
Xpel (XPEL) | 2013 | 179.07% |
InnovAge (INNV) | 2013 | 164.71% |
Sphere 3D (ANY) | 2013 | 162.03% |
Arcturus Therapeutics (ARCT) | 2013 | 161.45% |
Inovio Pharmaceuticals (INO) | 2013 | 152.44% |
JinkoSolar (JKS) | 2013 | 142.47% |
Galectin Therapeutics (GALT) | 2013 | 134.59% |
Retractable Technologies (RVP) | 2013 | 128.68% |
NextTrip (NTRP) | 2013 | 126.09% |
OLB (OLB) | 2013 | 125% |
Supercom (SPCB) | 2013 | 123.18% |
BioLife Solutions (BLFS) | 2013 | 122.22% |
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN) | 2013 | 122.22% |